Developmental stage at 6 years: A typically developing 6-year-old is in early childhood, transitioning into the school-age period, with rapid consolidation of language, executive skills, emotional regulation, peer relationships, self-concept, and adaptation to structured educational and social environments.
There is no relevant evidence in the supplied literature that defines a specific neurological-developmental stage for a typically developing 6-year-old or demonstrates that international relocation at this age causes neurological harm or impaired psychological development Unknown 2026.
Nor do the supplied NICE sources provide a relocation-specific causal risk estimate for mental-health or developmental harm at age 6 1,NICE CKS,NICE CKS.
What can reasonably be concluded: Moving country can be a substantial psychosocial transition because it may disrupt friendships, schooling, routines, language exposure, cultural familiarity, family support networks, and access to services; however, this statement is general developmental reasoning rather than a finding established by the supplied sources.
The likely impact is therefore individual and mediated by factors such as prior mental-health or neurodevelopmental needs, forced versus planned relocation, parental wellbeing, socioeconomic stress, continuity of education and healthcare, family cohesion, and the availability of social support after arrival.
Evidence threshold: The provided context does not contain longitudinal cohort studies, systematic reviews, or guideline recommendations comparing children who relocate internationally at age 6 with non-relocating peers on outcomes such as anxiety, depression, attachment, educational attainment, neurodevelopment, or psychiatric diagnosis Unknown 2026.
It would therefore be inaccurate to state that available evidence proves that relocating between countries at age 6 is inherently detrimental to mental health or psychological development.
Practical clinical framing: If a child is relocating, assess current emotional and behavioural functioning, developmental and educational needs, attachment and support systems, previous adverse experiences, and the planned continuity of school, primary care, and any specialist support NICE CKS,NICE CKS,NICE CKS.
Early review is particularly appropriate if there are emerging symptoms of anxiety, low mood, withdrawal, sleep disturbance, behavioural change, school refusal, regression, or impaired functioning following the move NICE CKS,NICE CKS,NICE CKS.
Key References
- NICE CKS: Autism in children
- NICE CKS: Mental health in students
- NICE CKS: Depression in children
- SmPC: Upstaza (Eladocagene exuparvovec) solution for infusion
- (Unknown, 2026): Abstracts of the 19th International Congress on Neuromuscular Diseases 7th – 11th July 2026
- (Unknown, 2024): Abstracts from the 56th European Society of Human Genetics (ESHG) Conference: Oral Presentations
- (Unknown, 2023): Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters